Ben Shen

This inventor holds 9 USPTO granted patents. Top assignees: Wisconsin Alumni Research Foundation, Indiana University. Active years: 2006-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ben Shen. Retrieved from https://idiyas.com/inventor/ben-shen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 9

% Patents Active = 22.2

Average Co-Inventor Count = 1.6

ph-index = 2

Forward Citations = 17(Granted Patents)

Company Filing History:

9 out of 4,249

Wisconsin Alumni Research Foundation

where one patent can have more than one assignee

Years Active: 2006-2014

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8652838 - [object Object] (2014-02-18),

2. 8637684 - Tautomycetin and tautomycetin analog biosynthesis (2014-01-28),

3. 8580977 - Tautomycetin and tautomycetin analog biosynthesis (2013-11-12),

4. 7452693 - Discrete acyltransferases associated with type I polyketide synthases and methods of use (2008-11-18),

5. 7416870 - Methods of directing C-O bond formation utilizing a type II polyketide synthase system (2008-08-26),

6. 7345069 - Oxidative activation and episulfonium ion-mediated DNA alkylation-based anticancer (2008-03-18),

7. 7153667 - Discrete acyltransferases associated with type I polyketide synthases and methods of use (2006-12-26),

8. 7122353 - Targeted carrier fusions for delivery of chemotherapeutic agents (2006-10-17),

9. 7105491 - Biosynthesis of enediyne compounds by manipulation of C-1027 gene pathway (2006-09-12),

Title: The Innovative Contributions of Ben Shen

Introduction

Ben Shen is a prominent inventor based in Verona, WI (US). He has made significant contributions to the field of biosynthetic research, holding a total of 9 patents. His work focuses on the development of compounds with potential antibacterial properties, showcasing his commitment to advancing medical science.

Latest Patents

Among his latest patents, one relates to the cloning and sequencing of a biosynthetic gene cluster that produces platensimycin and platencin. This invention also includes engineered microorganisms for the production of these compounds and methods for screening compounds with antibacterial activity. Another notable patent involves tautomycetin (TTN) and its analogs, along with methods for using TTN in the treatment of diseases related to SHP2 function.

Career Highlights

Throughout his career, Ben Shen has worked with esteemed organizations such as the Wisconsin Alumni Research Foundation and Indiana University. His research has not only contributed to the scientific community but has also paved the way for potential therapeutic applications.

Collaborations

Ben has collaborated with notable colleagues, including Yi-Qiang Cheng and Gong-Li Tang. These partnerships have enhanced his research efforts and expanded the impact of his inventions.

Conclusion

Ben Shen's innovative work in biosynthetic research and his numerous patents highlight his significant contributions to science and medicine. His dedication to developing new compounds with antibacterial properties is commendable and reflects the importance of innovation in addressing health challenges.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]